| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Michael Schaub, Kyra Fanghaenel, Charlotte Senn, Rudolf Stohle. Cannabis using schizophrenia patients treated with atypical neuroleptics: do their symptoms differ from those of cannabis abstainers? Substance use & misuse. vol 43. issue 14. 2009-03-10. PMID:19085437. |
cannabis using schizophrenia patients treated with atypical neuroleptics: do their symptoms differ from those of cannabis abstainers? |
2009-03-10 |
2023-08-12 |
Not clear |
| Michael Schaub, Kyra Fanghaenel, Charlotte Senn, Rudolf Stohle. Cannabis using schizophrenia patients treated with atypical neuroleptics: do their symptoms differ from those of cannabis abstainers? Substance use & misuse. vol 43. issue 14. 2009-03-10. PMID:19085437. |
since differing symptoms could also result from a tn-cannabis combination and might not be due to cannabis use per se, this study examined schizophrenia symptoms in a group of cannabis-using outpatients treated with atypical antipsychotics. |
2009-03-10 |
2023-08-12 |
Not clear |
| Michael Schaub, Kyra Fanghaenel, Charlotte Senn, Rudolf Stohle. Cannabis using schizophrenia patients treated with atypical neuroleptics: do their symptoms differ from those of cannabis abstainers? Substance use & misuse. vol 43. issue 14. 2009-03-10. PMID:19085437. |
forty-two schizophrenia outpatients participated and were divided into three groups: cannabis abstainers, moderate users, and daily users. |
2009-03-10 |
2023-08-12 |
Not clear |
| Michael Schaub, Kyra Fanghaenel, Charlotte Senn, Rudolf Stohle. Cannabis using schizophrenia patients treated with atypical neuroleptics: do their symptoms differ from those of cannabis abstainers? Substance use & misuse. vol 43. issue 14. 2009-03-10. PMID:19085437. |
thus, schizophrenia patients treated with atypical neuroleptics do not differ in symptom patterns whether using or not using cannabis. |
2009-03-10 |
2023-08-12 |
Not clear |
| Wolfram Kawohl, Wulf Rössle. [Cannabis and Schizophrenia: new findings in an old debate]. Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater. vol 22. issue 4. 2009-03-05. PMID:19080993. |
[cannabis and schizophrenia: new findings in an old debate]. |
2009-03-05 |
2023-08-12 |
Not clear |
| J Stirling, E J Barkus, L Nabosi, S Irshad, G Roemer, B Schreudergoidheijt, S Lewi. Cannabis-induced psychotic-like experiences are predicted by high schizotypy. Confirmation of preliminary results in a large cohort. Psychopathology. vol 41. issue 6. 2009-02-27. PMID:18787359. |
cannabis use has been identified as a possible risk factor for developing schizophrenia. |
2009-02-27 |
2023-08-12 |
Not clear |
| Michael Schaub, Kyra Fanghaenel, Rudolf Stohle. Reasons for cannabis use: patients with schizophrenia versus matched healthy controls. The Australian and New Zealand journal of psychiatry. vol 42. issue 12. 2009-02-27. PMID:19016094. |
reasons for cannabis use: patients with schizophrenia versus matched healthy controls. |
2009-02-27 |
2023-08-12 |
Not clear |
| Michael Schaub, Kyra Fanghaenel, Rudolf Stohle. Reasons for cannabis use: patients with schizophrenia versus matched healthy controls. The Australian and New Zealand journal of psychiatry. vol 42. issue 12. 2009-02-27. PMID:19016094. |
the aim of the present study was to compare self-reported reasons for cannabis use in patients with schizophrenia with those of matched healthy controls. |
2009-02-27 |
2023-08-12 |
Not clear |
| C J Lake. A literature review to assess the reliability and validity of measures appropriate for use in research to evaluate the efficacy of a brief harm reduction strategy in reducing cannabis use among people with schizophrenia in acute inpatient settings. Journal of psychiatric and mental health nursing. vol 15. issue 9. 2009-02-13. PMID:18844804. |
a literature review to assess the reliability and validity of measures appropriate for use in research to evaluate the efficacy of a brief harm reduction strategy in reducing cannabis use among people with schizophrenia in acute inpatient settings. |
2009-02-13 |
2023-08-12 |
Not clear |
| C J Lake. A literature review to assess the reliability and validity of measures appropriate for use in research to evaluate the efficacy of a brief harm reduction strategy in reducing cannabis use among people with schizophrenia in acute inpatient settings. Journal of psychiatric and mental health nursing. vol 15. issue 9. 2009-02-13. PMID:18844804. |
there is a growing body of evidence looking at the effects of cannabis use on those with schizophrenia with concerning results. |
2009-02-13 |
2023-08-12 |
Not clear |
| C J Lake. A literature review to assess the reliability and validity of measures appropriate for use in research to evaluate the efficacy of a brief harm reduction strategy in reducing cannabis use among people with schizophrenia in acute inpatient settings. Journal of psychiatric and mental health nursing. vol 15. issue 9. 2009-02-13. PMID:18844804. |
this literature review assesses the self-report measures that have been reliability and validity tested in populations of people with schizophrenia who use cannabis and reports on their appropriateness for use in further research studies. |
2009-02-13 |
2023-08-12 |
Not clear |
| Johannes Lodewikus Roos, Herman Walter Pretorius, Maria Karayiorgo. Clinical characteristics of an Afrikaner founder population recruited for a schizophrenia genetic study. Annals of the New York Academy of Sciences. vol 1151. 2009-02-10. PMID:19154519. |
approximately half of male schizophrenia patients and a quarter of female patients in the afrikaner schizophrenia database used or abused cannabis. |
2009-02-10 |
2023-08-12 |
human |
| Cécile Henquet, Marta Di Forti, Paul Morrison, Rebecca Kuepper, Robin M Murra. Gene-environment interplay between cannabis and psychosis. Schizophrenia bulletin. vol 34. issue 6. 2009-02-03. PMID:18723841. |
cannabis use is considered a contributory cause of schizophrenia and psychotic illness. |
2009-02-03 |
2023-08-12 |
Not clear |
| Cécile Henquet, Marta Di Forti, Paul Morrison, Rebecca Kuepper, Robin M Murra. Gene-environment interplay between cannabis and psychosis. Schizophrenia bulletin. vol 34. issue 6. 2009-02-03. PMID:18723841. |
this review will therefore consider the interplay between genes and exposure to cannabis in the development of psychotic symptoms and schizophrenia. |
2009-02-03 |
2023-08-12 |
Not clear |
| Jim van Os, Bart Pf Rutten, Richie Poulto. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophrenia bulletin. vol 34. issue 6. 2009-02-03. PMID:18791076. |
concern is building about high rates of schizophrenia in large cities, and among immigrants, cannabis users, and traumatized individuals, some of which likely reflects the causal influence of environmental exposures. |
2009-02-03 |
2023-08-12 |
Not clear |
| Stephane Potvin, Adham Mancini-Marie, Cherine Fahim, Boualem Mensour, Emmanuel Sti. Processing of social emotion in patients with schizophrenia and substance use disorder: an fMRI study. Social neuroscience. vol 2. issue 2. 2008-12-12. PMID:18633810. |
schizophrenia patients (dsm-iv criteria) were divided into two groups: patients with (n=12) and without (n=11) substance use (alcohol and/or cannabis). |
2008-12-12 |
2023-08-12 |
Not clear |
| Chris Hollis, Madeleine J Groom, Debasis Das, Tim Calton, Alan T Bates, Hayley K Andrews, Georgina M Jackson, Peter F Liddl. Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD). Schizophrenia research. vol 105. issue 1-3. 2008-12-11. PMID:18768298. |
different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (adhd). |
2008-12-11 |
2023-08-12 |
Not clear |
| Chris Hollis, Madeleine J Groom, Debasis Das, Tim Calton, Alan T Bates, Hayley K Andrews, Georgina M Jackson, Peter F Liddl. Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD). Schizophrenia research. vol 105. issue 1-3. 2008-12-11. PMID:18768298. |
controversy exists regarding whether young people at risk for schizophrenia are at increased risk of adverse mental effects of cannabis use. |
2008-12-11 |
2023-08-12 |
Not clear |
| Daniele Fabio Zullino, Lakshmi Waber, Yasser Khazaa. Cannabis and the course of schizophrenia. The American journal of psychiatry. vol 165. issue 10. 2008-11-18. PMID:18829891. |
cannabis and the course of schizophrenia. |
2008-11-18 |
2023-08-12 |
Not clear |
| William F Costai. The effects of cannabis abuse on the symptoms of schizophrenia: patient perspectives. International journal of mental health nursing. vol 17. issue 4. 2008-10-24. PMID:18666905. |
the effects of cannabis abuse on the symptoms of schizophrenia: patient perspectives. |
2008-10-24 |
2023-08-12 |
human |